AF174

Human TACI/TNFRSF13B Antibody, R&D Systems™

Manufacturer: R&D Systems

Select a Size

Pack Size SKU Availability Price
Each of 1 AF174-Each-of-1 In Stock ₹ 50,997.00

AF174 - Each of 1

₹ 50,997.00

In Stock

Quantity

1

Base Price: ₹ 50,997.00

GST (18%): ₹ 9,179.46

Total Price: ₹ 60,176.46

Antigen

TACI/TNFRSF13B/CVID

Classification

Polyclonal

Conjugate

Unconjugated

Gene Accession No.

Q53F36

Gene Symbols

TNFRSF13B

Immunogen

Mouse myeloma cell line NS0-derived recombinant human TACI/TNFRSF13B Ser2-Thr166 Accession # Q53F36

Quantity

100 μg

Primary or Secondary

Primary

Test Specificity

Detects human TACI in direct ELISAs and Western blots. In direct ELISAs, less than 5% cross-reactivity with recombinant mouse TACI and recombinant human BCMA is observed.

Target Species

Human

Isotype

IgG

Applications

Western Blot, Immunohistochemistry, Blockade of Receptor-ligand Interaction

Concentration

LYOPH

Dilution

Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL, Blockade of Receptor-ligand Interaction

Gene Alias

CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF13B, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B

Host Species

Goat

Purification Method

Affinity Purified

Regulatory Status

RUO

Gene ID (Entrez)

23495

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Content And Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Description

  • TACI/TNFRSF13B/CVID Polyclonal specifically detects TACI/TNFRSF13B/CVID in Human samples
  • It is validated for Western Blot, Immunohistochemistry, Blockade of Receptor-ligand Interaction.